D. Hackett

发表

Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder

M. Lader, P. Meoni, D. Hackett, 2004, Depression and anxiety.

Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR.

D. Sheehan, S. Montgomery, V. Haudiquet, 2002, Journal of psychiatric research.

Efficacy of short and long-term venlafaxine ER treatment on somatic and psychic symptoms of GAD

C. White, P. Meoni, D. Hackett, 2000, European Neuropsychopharmacology.

Efficacy of venlafaxine in depressive illness in general practice

Y. Lecrubier, M. Bourin, P. Danjou, 1997, Acta psychiatrica Scandinavica.

P.3.063 Long-term treatment of generalized social anxiety disorder with venlafaxine XR

M. Stein, M. Pollack, D. Hackett, 2003, European Neuropsychopharmacology.

Venlafaxine ER as a Treatment for Generalized Anxiety Disorder in Older Adults: Pooled Analysis of Five Randomized Placebo‐Controlled Clinical Trials

I. Katz, G. Alexopoulos, C. F. Reynolds, 2002, Journal of the American Geriatrics Society.

Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms

J. Davidson, M. Cantillon, V. Haudiquet, 2002, Depression and anxiety.

Efficacy of venlafaxine and placebo during long‐term treatment of depression: a pooled analysis of relapse rates

A. Entsuah, D. Hackett, R. Rudolph, 1996, International clinical psychopharmacology.

Drug effects in a novel biphasic writing syndrome induced by acetylcholine in mice.

W. R. Buckett, D. Hackett, W. Buckett, 1975, European journal of pharmacology.

Efficacy of venlafaxine ER in social adjustment in patients with generalized anxiety disorder

P. Boyer, V. Haudiquet, V. Mahé, 2000, European Neuropsychopharmacology.

Safety and tolerance profile of venlafaxine

P. Danjou, D. Hackett, 1995, International clinical psychopharmacology.

A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia.

H. Wetzel, O. Benkert, G. Gründer, 1996, Journal of psychiatric research.

Neurobiologic basis of antidepressant safety profiles

E. Salinas, D. Hackett, 1997, European Psychiatry.

A preclinical evaluation of the discriminative and reinforcing properties of lisdexamfetamine in comparison to d -amfetamine, methylphenidate and modafinil

J. Gosden, D. Heal, C. France, 2013, Neuropharmacology.

Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine

P. Silverstone, R. Entsuah, D. Hackett, 2002, International clinical psychopharmacology.

Venlafaxine versus placebo in the preventive treatment of recurrent major depression.

S. Montgomery, R. Entsuah, D. Hackett, 2004, The Journal of clinical psychiatry.

Estimation of symptom-free days in generalized anxiety disorder

G. Wan, M. Tedeschi, Huabin F. Zhang, 2006, Current medical research and opinion.

Effects of lisdexamfetamine in a rat model of binge-eating

F. Murray, P. Hutson, D. Heal, 2015, Journal of psychopharmacology.

Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.

Y. Brault, E. Salinas, P. Meoni, 2001, The Journal of clinical psychiatry.

Venlafaxine XR in the treatment of anxiety

D. Hackett, 2000, Acta psychiatrica Scandinavica. Supplementum.

Venlafaxine Extended Release (ER) in the Treatment of Generalised Anxiety Disorder

C. Allgulander, E. Salinas, D. Hackett, 2001, British Journal of Psychiatry.

Lisdexamfetamine and immediate release d-amfetamine – Differences in pharmacokinetic/pharmacodynamic relationships revealed by striatal microdialysis in freely-moving rats with simultaneous determination of plasma drug concentrations and locomotor activity

J. Gosden, D. Heal, H. Rowley, 2012, Neuropharmacology.

A RANDOMISED, DOUBLE‐BLIND, PARALLEL‐GROUP COMPARISON OF VENLAFAXINE AND DOTHIEPIN IN GERIATRIC PATIENTS WITH MAJOR DEPRESSION

D. Hackett, SN Mahapatra, 1997, International journal of clinical practice.

A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.

M. Toussaint, R. Luthringer, J. Macher, 1996, Psychopharmacology bulletin.

A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression

J. Samuélian, D. Hackett, J.C. Samuelian, 1998, Journal of psychopharmacology.

Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats

J. Gosden, D. Heal, H. Rowley, 2014, Journal of psychopharmacology.

Comparing onset of effect of antidepressants: Pragmatic considerations on methods and end-points

D. Hackett, 1998, European Psychiatry.

Social adjustment in generalised anxiety disorder: a long-term placebo-controlled study of venlafaxine extended release

P. Boyer, V. Mahé, D. Hackett, 2004, European Psychiatry.

Predictors of Outcome Following Venlafaxine Extended-Release Treatment of DSM-IV Generalized Anxiety Disorder: A Pooled Analysis of Short- and Long-Term Studies

M. Pollack, M. Otto, P. Meoni, 2003, Journal of clinical psychopharmacology.

Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia.

J. Guelfi, G. Magni, J. Guichoux, 1995, The Journal of clinical psychiatry.

Subjective and reinforcing effects of modafinil in rats

J. Gosden, D. Heal, D. Hackett, 2014 .

Venlafaxine prevents recurrence of depression

R. Entsuah, D. Hackett, R. Rudolph, 1998, European Neuropsychopharmacology.

P-2-99 A randomized double-blind comparison of venlafaxine, imipramine and placebo in general practice patients with mild moderate depression

T. Nicholas, P. Danjou, C. Blanchard, 1995, European Neuropsychopharmacology.

A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder

V. Haudiquet, E. Salinas, D. Hackett, 2003, European Psychiatry.

A microdialysis and behavioural investigation of modafinil in freely moving rats

D. Heal, H. Rowley, D. Hackett, 2014 .

A preclinical evaluation of the discriminative and reinforcing properties of lisdexamfetamine in comparison to d -amfetamine, methylphenidate and modafinil

J. Gosden, D. Heal, C. France, 2013, Neuropharmacology.